These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15820529)

  • 1. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
    Zhen X; Goswami S; Friedman E
    Pharmacol Biochem Behav; 2005 Apr; 80(4):597-601. PubMed ID: 15820529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Zhang H; Ma L; Wang F; Chen J; Zhen X
    Neuropharmacology; 2007 Jul; 53(1):125-33. PubMed ID: 17553535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.
    Ma LQ; Liu C; Wang F; Xie N; Gu J; Fu H; Wang JH; Cai F; Liu J; Chen JG
    J Neurophysiol; 2009 May; 101(5):2230-8. PubMed ID: 19225177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons.
    Ming Y; Zhang H; Long L; Wang F; Chen J; Zhen X
    J Neurochem; 2006 Aug; 98(4):1316-23. PubMed ID: 16771826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain.
    Jin LQ; Goswami S; Cai G; Zhen X; Friedman E
    J Neurochem; 2003 Apr; 85(2):378-86. PubMed ID: 12675914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
    Zhang ZJ; Jiang XL; Zhang SE; Hough CJ; Li H; Chen JG; Zhen XC
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):134-8. PubMed ID: 15911136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro.
    Chu HY; Yang Z; Zhao B; Jin GZ; Hu GY; Zhen X
    Brain Res; 2010 Jul; 1343():20-7. PubMed ID: 20420815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol-linked novel D(1) dopamine receptor facilitates long-term depression in rat hippocampal CA1 synapses.
    Liu J; Wang W; Wang F; Cai F; Hu ZL; Yang YJ; Chen J; Chen JG
    Neuropharmacology; 2009 Aug; 57(2):164-71. PubMed ID: 19465033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
    Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
    Gulwadi AG; Korpinen CD; Mailman RB; Nichols DE; Sit SY; Taber MT
    J Pharmacol Exp Ther; 2001 Feb; 296(2):338-44. PubMed ID: 11160615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
    Pinna A; Di Chiara G
    Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism.
    Chu HY; Wu Q; Zhou S; Cao X; Zhang A; Jin GZ; Hu GY; Zhen X
    J Neurosci Res; 2011 Aug; 89(8):1259-66. PubMed ID: 21538463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
    Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A
    J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action.
    Yu Y; Wang JR; Sun PH; Guo Y; Zhang ZJ; Jin GZ; Zhen X
    J Neurochem; 2008 Feb; 104(4):946-56. PubMed ID: 18005341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.